|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00570 TRAD CHI MED
Nominal 
1.790 -0.010 (-0.556%) Profitability Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -1.015% | 0.150% | 3.535% | 2.123% | 5.564% |
| ROAE (%) | -1.642% | 0.255% | 6.219% | 3.833% | 10.231% |
| Return on Capital Employed (%) | -1.390% | 0.198% | 4.634% | 2.994% | 6.997% |
Margin Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 48.092% | 47.586% | 51.178% | 50.324% | 62.086% |
| EBITDA Margin (%) | 5.801% | 8.590% | 13.770% | 14.656% | 18.580% |
| Pre-tax Profit Margin (%) | -2.497% | 0.988% | 6.757% | 5.873% | 13.228% |
| Net Profit Margin (%) | -2.320% | 0.327% | 7.092% | 5.344% | 10.145% |
Liquidity Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 2.290 X | 2.415 X | 2.122 X | 1.778 X | 2.077 X |
| Quick Ratio (X) | 1.810 X | 1.802 X | 1.483 X | 1.181 X | 1.502 X |
Leverage Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 28.811% | 31.744% | 35.426% | 35.606% | 37.726% |
| Total Debt / Total Assets (%) | 7.709% | 11.452% | 13.921% | 14.150% | 13.915% |
| Net Debt / Total Assets (%) | -4.478% | 0.424% | 5.781% | 5.549% | 5.960% |
| Total Debt / Shareholders' Funds (%) | 12.182% | 18.938% | 24.386% | 25.003% | 25.679% |
| Long Term Debt / Shareholders' Funds (%) | 1.271% | 8.922% | 10.353% | 2.623% | 14.671% |
| Net Debt / Shareholders' Funds (%) | -7.076% | 0.701% | 10.127% | 9.805% | 10.999% |
| Net Cash / (Debt) ($) | 1.448B | (148.727M) | (2.143B) | (1.978B) | (2.169B) |
| Net Cash / (Debt) per share ($) | 0.288 | (0.030) | (0.426) | (0.393) | (0.431) |
| Total Debt / Capital Employed (%) | 10.131% | 14.729% | 18.605% | 19.748% | 18.330% |
| Interest Coverage Ratio (X) | N/A | 1.951 X | 7.152 X | 4.807 X | 12.351 X |
Efficiency Analysis
| 2025/12 | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 202.539 Day | 226.554 Day | 247.511 Day | 284.642 Day | 251.414 Day |
| Receivables Turnover (Day) | 204.814 Day | 191.681 Day | 169.097 Day | 203.656 Day | 123.521 Day |
| Payables Turnover (Day) | 55.006 Day | 55.044 Day | 46.644 Day | 50.804 Day | 38.862 Day |
| Remarks: | Real time quote last updated: 26/03/2026 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -342,070 |
| %Change | -- |
| EPS / (LPS) | RMB -0.068 |
| NBV Per Share (¥) | RMB 4.065 |